Transient improvement of pyruvate metabolism after coenzyme Q therapy in Kearns-Sayre syndrome: MRS study

Yonsei Medical Journal

Volumn 41, Issue 5, 2000, Pages 676-679

  Choi, Chulhee ^a,b   Sunwoo, Il Nam ^b   Kim, Hyun Sook ^b   Kim, Dong Ik ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

CoQ; Kearns Sayre syndrome; Lactate; MRS

Indexed keywords

LACTIC ACID; PYRUVIC ACID; UBIQUINONE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG MONITORING; ENZYME THERAPY; FEMALE; HUMAN; KEARNS SAYRE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; PROTON NUCLEAR MAGNETIC RESONANCE; PTOSIS; TREATMENT OUTCOME;

EID: 0033773128     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2000.41.5.676     Document Type: Article

References (10)

1. DiMauro S, Bonilla E, Zeviani M, Nakagawa M, De Vivo DC. Mitochondrial myopathies. Ann Neurol 1985;17:521-38.
2. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative disease? Science 1992;256:628-32.
3. Miller BL. A review of chemical issues in IH NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52.
4. Matthews PM, Andermann F, Silver K, Karpati G, Arnold DL. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993;43:2484-90.
5. Kuwabara T, Watanabe H, Tanaka K, Tsuji S, Ohkubo M, Ito T, et al. Mitochondrial encephalomyopathy: Elevated visual cortex lactate unresponsive to photic stimulation-a localized 1H-MRS study. Neurology 1994; 44:557-9.
6. Choi C, Sunwoo IN, Kim TS, Jeon P. MRI follow-up study and 1H-MR spectroscopic finding in a patient with Kearns-Sayre syndrome. J Korean Neurol Assoc 1998; 16:388-91.
7. Peterson PL. The treatment of mitochondrial myopathies and encephalomyopathies. Biochem Biophys Acta 1995; 1271:275-80.
8. 10 in Kearns-Sayre syndrome. Neurology 1985; 35:372-7.
9. 10 therapy. Ophthalmologica 1994;208:342-3.
10. Pavlakis SG, Kingsley PB, Kaplan GP, Stacpoole PW, O'Shea M, Lustbader D. Magnetic resonance spectroscopy: use in monitoring MELAS treatment. Arch Neurol 1998; 55:849-52.